Your request to link to rcsb for GRIA3

  • 1FTJ: crystal structure of the glur2 ligand binding core (s1s2j) in complex with glutamate at 1.9 resolution (10.1016/S0896-6273(00)00094-5 )
  • 1FTK: crystal structure of the glur2 ligand binding core (s1s2i) in complex with kainate at 1.6 a resolution (10.1016/S0896-6273(00)00094-5 )
  • 1FTL: crystal structure of the glur2 ligand binding core (s1s2j) in complex with the antagonist dnqx at 1.8 a resolution (10.1016/S0896-6273(00)00094-5 )
  • 1FTM: crystal structure of the glur2 ligand binding core (s1s2j) in complex with ampa at 1.7 resolution (10.1016/S0896-6273(00)00094-5 )
  • 1FTO: crystal structure of the glur2 ligand binding core (s1s2j) in the apo state at 2.0 a resolution (10.1016/S0896-6273(00)00094-5 )
  • 1FW0: crystal structure of the glur2 ligand binding core (s1s2j) in complex with kainate at 2.0 a resolution (10.1016/S0896-6273(00)00094-5 )
  • 1GR2: structure of a glutamate receptor ligand binding core (glur2) complexed with kainate (10.1038/27692 )
  • 1LB8: crystal structure of the non-desensitizing glur2 ligand binding core mutant (s1s2j-l483y) in complex with ampa at 2.3 resolution (10.1038/417245A )
  • 1LB9: crystal structure of the non-desensitizing glur2 ligand binding core mutant (s1s2j-l483y) in complex with antagonist dnqx at 2.3 a resolution (10.1038/417245A )
  • 1LBB: crystal structure of the glur2 ligand binding domain mutant (s1s2j- n754d) in complex with kainate at 2.1 a resolution (10.1038/417245A )
  • 1LBC: crystal structure of glur2 ligand binding core (s1s2j- n775s) in complex with cyclothiazide (ctz) as well as glutamate at 1.8 a resolution (10.1038/417245A )
  • 1M5B: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with 2-me-tet-ampa at 1.85 a resolution. (10.1016/S0022-2836(02)00650-2 )
  • 1M5C: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with br-hibo at 1.65 a resolution (10.1016/S0022-2836(02)00650-2 )
  • 1M5D: x-ray structure of the glur2 ligand binding core (s1s2j-y702f) in complex with br-hibo at 1.73 a resolution (10.1016/S0022-2836(02)00650-2 )
  • 1M5E: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with acpa at 1.46 a resolution (10.1016/S0022-2836(02)00650-2 )
  • 1M5F: x-ray structure of the glur2 ligand binding core (s1s2j-y702f) in complex with acpa at 1.95 a resolution (10.1016/S0022-2836(02)00650-2 )
  • 1MM6: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate in a non zinc crystal form at 2.15 angstroms resolution (10.1021/BI020583K )
  • 1MM7: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate in a zinc crystal form at 1.65 angstroms resolution (10.1021/BI020583K )
  • 1MQD: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-des-me-ampa at 1.46 a resolution. crystallization in the presence of lithium sulfate. (10.1016/S0014-5793(02)03496-8 )
  • 1MQG: crystal structure of the glur2 ligand binding core (s1s2j) in complex with iodo-willardiine at 2.15 angstroms resolution (10.1038/NN1091 )
  • 1MQH: crystal structure of the glur2 ligand binding core (s1s2j) in complex with bromo-willardiine at 1.8 angstroms resolution (10.1038/NN1091 )
  • 1MQI: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fluoro-willardiine at 1.35 angstroms resolution (10.1038/NN1091 )
  • 1MQJ: crystal structure of the glur2 ligand binding core (s1s2j) in complex with willardiine at 1.65 angstroms resolution (10.1038/NN1091 )
  • 1MS7: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-des-me-ampa at 1.97 a resolution, crystallization in the presence of zinc acetate (10.1016/S0014-5793(02)03496-8 )
  • 1MXU: crystal structure of the glur2 ligand binding core (s1s2j) in complex with bromo-willardiine (control for the crystal titration experiments) (10.1021/BI020632T )
  • 1MXV: crystal titration experiments (ampa co-crystals soaked in 10 mm brw) (10.1021/BI020632T )
  • 1MXW: crystal titration experiments (ampa co-crystals soaked in 1 mm brw) (10.1021/BI020632T )
  • 1MXX: crystal titration experiments (ampa co-crystals soaked in 100 um brw) (10.1021/BI020632T )
  • 1MXY: crystal titration experiments (ampa co-crystals soaked in 10 um brw) (10.1021/BI020632T )
  • 1MXZ: crystal titration experiments (ampa co-crystals soaked in 1 um brw) (10.1021/BI020632T )
  • 1MY0: crystal titration experiments (ampa co-crystals soaked in 100 nm brw) (10.1021/BI020632T )
  • 1MY1: crystal titration experiments (ampa co-crystals soaked in 10 nm brw) (10.1021/BI020632T )
  • 1MY2: crystal titration experiment (ampa complex control) (10.1021/BI020632T )
  • 1MY3: crystal structure of glutamate receptor ligand-binding core in complex with bromo-willardiine in the zn crystal form (10.1021/BI020632T )
  • 1MY4: crystal structure of glutamate receptor ligand-binding core in complex with iodo-willardiine in the zn crystal form (10.1021/BI020632T )
  • 1N0T: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with the antagonist (s)-atpo at 2.1 a resolution. (10.1021/JM020989V )
  • 1NNK: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-atpa at 1.85 a resolution. crystallization with zinc ions. (10.1021/JM021020+ )
  • 1NNP: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-atpa at 1.9 a resolution. crystallization without zinc ions. (10.1021/JM021020+ )
  • 1P1N: glur2 ligand binding core (s1s2j) mutant l650t in complex with kainate (10.1073/PNAS.1037393100 )
  • 1P1O: crystal structure of the glur2 ligand-binding core (s1s2j) mutant l650t in complex with quisqualate (10.1073/PNAS.1037393100 )
  • 1P1Q: crystal structure of the glur2 ligand binding core (s1s2j) l650t mutant in complex with ampa (10.1073/PNAS.1037393100 )
  • 1P1U: crystal structure of the glur2 ligand-binding core (s1s2j) l650t mutant in complex with ampa (ammonium sulfate crystal form) (10.1073/PNAS.1037393100 )
  • 1P1W: crystal structure of the glur2 ligand-binding core (s1s2j) with the l483y and l650t mutations and in complex with ampa (10.1073/PNAS.1037393100 )
  • 1SYH: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-cpw399 at 1.85 a resolution. (10.1124/MOL.104.002931 )
  • 1SYI: x-ray structure of the y702f mutant of the glur2 ligand- binding core (s1s2j) in complex with (s)-cpw399 at 2.1 a resolution. (10.1124/MOL.104.002931 )
  • 1WVJ: exploring the glur2 ligand-binding core in complex with the bicyclic ampa analogue (s)-4-ahcp (10.1111/J.1742-4658.2005.04583.X )
  • 1XHY: x-ray structure of the y702f mutant of the glur2 ligand-binding core (s1s2j) in complex with kainate at 1.85 a resolution (10.1124/MOL.104.002931 )
  • 2AIX: x-ray structure of the glur2 ligand-binding core (s1s2j) in complex with (s)-thio-atpa at 2.2 a resolution.
  • 2AL4: crystal structure of the glur2 ligand binding core (s1s2j) in complex with quisqualate and cx614. (10.1523/JNEUROSCI.2567-05.2005 )
  • 2AL5: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fluoro-willardiine and aniracetam (10.1523/JNEUROSCI.2567-05.2005 )
  • 2ANJ: crystal structure of the glur2 ligand binding core (s1s2j-y450w) mutant in complex with the partial agonist kainic acid at 2.1 a resolution (10.1074/JBC.M507800200 )
  • 2CMO: the structure of a mixed glur2 ligand-binding core dimer in complex with (s)-glutamate and the antagonist (s)-ns1209 03-jul-06 2cmo 1 title (10.1016/J.JMB.2006.01.024 )
  • 2GFE: crystal structure of the glur2 a476e s673d ligand binding core mutant at 1.54 angstroms resolution (10.1523/JNEUROSCI.1519-06.2006 )
  • 2I3V: measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: structure of g725c mutant (10.1016/J.CELL.2006.08.037 )
  • 2I3W: measurement of conformational changes accompanying desensitization in an ionotropic glutamate receptor: structure of s729c mutant (10.1016/J.CELL.2006.08.037 )
  • 2P2A: x-ray structure of the glur2 ligand binding core (s1s2j) in complex with 2-bn-tet-ampa at 2.26a resolution (10.1021/JM061439Q )
  • 2XX7: crystal structure of 1-(4-(1-pyrrolidinylcarbonyl)phenyl)-3- (trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazole in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
  • 2XX8: crystal structure of n,n-dimethyl-4-(3-(trifluoromethyl)-4, 5,6,7-tetrahydro-1h-indazol-1-yl)benzamide in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
  • 2XX9: crystal structure of 1-((2-fluoro-4-(3-(trifluoromethyl)-4,5,6,7- tetrahydro-1h-indazol-1-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 2.2a resolution. (10.1021/JM100679E )
  • 2XXH: crystal structure of 1-(4-(2-oxo-2-(1-pyrrolidinyl)ethyl)phenyl)-3- (trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazole in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 1.5a resolution. (10.1021/JM100679E )
  • 2XXI: crystal structure of 1-((4-(3-(trifluoromethyl)-6,7-dihydropyrano(4,3 -c(pyrazol-1(4h)-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the rat glua2 receptor and glutamate at 1.6a resolution. (10.1021/JM100679E )
  • 3B6Q: crystal structure of the glur2 ligand binding core (s1s2j) mutant t686a in complex with glutamate at 2.0 resolution (10.1523/JNEUROSCI.3309-07.2008 )
  • 3B6T: crystal structure of the glur2 ligand binding core (s1s2j) t686a mutant in complex with quisqualate at 2.1 resolution (10.1523/JNEUROSCI.3309-07.2008 )
  • 3B6W: crystal structure of the glur2 ligand binding core (s1s2j) t686s mutant in complex with glutamate at 1.7 resolution (10.1523/JNEUROSCI.3309-07.2008 )
  • 3B7D: crystal structure of the glur2 ligand binding core (hs1s2j) in complex with cnqx at 2.5 a resolution (10.1126/SCIENCE.1146317 )
  • 3BBR: crystal structure of the iglur2 ligand binding core (s1s2j-n775s) in complex with a dimeric positive modulator as well as glutamate at 2.25 a resolution (10.1016/J.CHEMBIOL.2007.10.012 )
  • 3BFT: structure of the ligand-binding core of glur2 in complex with the agonist (s)-tdpa at 2.25 a resolution (10.1021/JM701126W )
  • 3BFU: structure of the ligand-binding core of glur2 in complex with the agonist (r)-tdpa at 1.95 a resolution (10.1021/JM701126W )
  • 3BKI: crystal structure of the glur2 ligand binding core (s1s2j) in complex with fqx at 1.87 angstroms (10.1021/JM701517B )
  • 3DLN: crystal structure of the binding domain of the ampa subunit glur3 bound to glutamate (10.1002/PROT.22274 )
  • 3DP4: crystal structure of the binding domain of the ampa subunit glur3 bound to ampa (10.1002/PROT.22274 )
  • 3DP6: crystal structure of the binding domain of the ampa subunit glur2 bound to glutamate (10.1002/PROT.22274 )
  • 3EN3: crystal structure of the glur4 ligand-binding domain in complex with kainate (10.1021/BI8013196 )
  • 3EPE: crystal structure of the glur4 ligand-binding domain in complex with glutamate (10.1021/BI8013196 )
  • 3H03: crystal structure of the binding domain of the ampa subunit glur2 bound to ubp277 (10.1021/BI900107M )
  • 3H06: crystal structure of the binding domain of the ampa subunit glur2 bound to the willardiine antagonist, ubp282 (10.1021/BI900107M )
  • 3H6T: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and cyclothiazide at 2.25 a resolution (10.1016/J.JMB.2009.07.002 )
  • 3H6U: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns1493 at 1.85 a resolution (10.1016/J.JMB.2009.07.002 )
  • 3H6V: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns5206 at 2.10 a resolution (10.1016/J.JMB.2009.07.002 )
  • 3H6W: crystal structure of the iglur2 ligand-binding core (s1s2j-n754s) in complex with glutamate and ns5217 at 1.50 a resolution (10.1016/J.JMB.2009.07.002 )
  • 3IJO: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, althiazide (10.1021/BI901127S )
  • 3IJX: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, hydrochlorothiazide (10.1021/BI901127S )
  • 3IK6: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, chlorothiazide (10.1021/BI901127S )
  • 3IL1: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, idra-21 (10.1021/BI901127S )
  • 3ILT: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, trichlormethiazide (10.1021/BI901127S )
  • 3ILU: crystal structure of the ampa subunit glur2 bound to the allosteric modulator, hydroflumethiazide (10.1021/BI901127S )
  • 3KEI: crystal structure of the glua4 ligand-binding domain l651v mutant in complex with glutamate (10.1523/JNEUROSCI.4558-09.2010 )
  • 3KFM: crystal structure of the glua4 ligand-binding domain l651v mutant in complex with kainate (10.1523/JNEUROSCI.4558-09.2010 )
  • 3KGC: isolated ligand binding domain dimer of glua2 ionotropic glutamate receptor in complex with glutamate, ly 404187 and zk 200775
  • 3LSF: piracetam bound to the ligand binding domain of glua2 (10.1021/JM901905J )
  • 3LSL: piracetam bound to the ligand binding domain of glua2 (flop form) (10.1021/JM901905J )
  • 3LSW: aniracetam bound to the ligand binding domain of glua3 (10.1021/JM901905J )
  • 3LSX: piracetam bound to the ligand binding domain of glua3 (10.1021/JM901905J )
  • 3M3F: pepa bound to the ligand binding domain of glua3 (flop form) (10.1021/BI1000678 )
  • 3M3K: ligand binding domain (s1s2) of glua3 (flop) (10.1021/BI1000678 )
  • 3M3L: pepa bound to the ligand binding domain of glua2 (flop form) (10.1021/BI1000678 )
  • 3O21: high resolution structure of glua3 n-terminal domain (ntd) (10.1038/EMBOJ.2011.17 )
  • 3P3W: structure of a dimeric glua3 n-terminal domain (ntd) at 4.2 a resolution (10.1038/EMBOJ.2011.17 )
  • 3PD8: x-ray structure of the ligand-binding core of glua2 in complex with (s)-7-hpca at 2.5 a resolution (10.1021/JM101218A )
  • 3PD9: x-ray structure of the ligand-binding core of glua2 in complex with (r)-5-hpca at 2.1 a resolution (10.1021/JM101218A )
  • 3RN8: crystal structure of iglur2 ligand binding domain and symmetrical carboxyl containing potentiator (10.1124/MOL.110.070243 )
  • 3RNN: crystal structure of iglur2 ligand binding domain with symmetric sulfonamide containing potentiator (10.1124/MOL.110.070243 )
  • 3RT6: fluorowillardiine bound to the ligand binding domain of glua3 (10.1124/MOL.111.071688 )
  • 3RT8: chlorowillardiine bound to the ligand binding domain of glua3 (10.1124/MOL.111.071688 )
  • 3RTF: chlorowillardiine bound to the ligand binding domain of glua2 (10.1124/MOL.111.071688 )
  • 3RTW: nitrowillardiine bound to the ligand binding domain of glua2 (10.1124/MOL.111.071688 )
  • 3T93: glutamate bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3T96: iodowillardiine bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3T9H: kainate bound to a double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3T9U: cnqx bound to an oxidized double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3T9V: cnqx bound to a reduced double cysteine mutant (a452c/s652c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3T9X: glutamate bound to a double cysteine mutant (v484c/e657c) of the ligand binding domain of glua2 (10.1074/JBC.M111.269001 )
  • 3TDJ: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam-97 at 1.95 a resolution (10.1042/BJ20111221 )
  • 3TKD: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and cyclothiazide at 1.45 a resolution (10.1042/BJ20111221 )
  • 3TZA: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (s)-2-amino-3-(2-(2-carboxyethyl)-5- chloro-4-nitrophenyl)propionic acid at 1.9a resolution (10.1021/JM200862H )
  • 4F1Y: cnqx bound to the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F22: kainate bound to the k660a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F29: quisqualate bound to the ligand binding domain of glua3i (10.1021/BI3001837 )
  • 4F2O: quisqualate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F2Q: quisqualate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F31: kainate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F39: kainate bound to the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F3B: glutamate bound to the d655a mutant of the ligand binding domain of glua3 (10.1021/BI3001837 )
  • 4F3G: kainate bound to the ligand binding domain of glua3i (10.1021/BI3001837 )
  • 4G8M: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the agonist cbg-iv at 2.05a resolution (10.1016/J.JSB.2012.07.001 )
  • 4GXS: ligand binding domain of glua2 (ampa/glutamate receptor) bound to (-)- kaitocephalin (10.1074/JBC.M112.416362 )
  • 4H8J: structure of glua2-lbd in complex with mes
  • 4IGT: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the agonist za302 at 1.24a resolution (10.1021/JM301433M )
  • 4ISU: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (2r)-ikm-159 at 2.3a resolution. (10.1021/JM301590Z )
  • 4IY5: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and cx516 at 2.0 a resolution (10.1107/S0907444913011839 )
  • 4IY6: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and me-cx516 at 1.72 a resolution (10.1107/S0907444913011839 )
  • 4L17: glua2-l483y-a665c ligand-binding domain in complex with the antagonist dnqx (10.1016/J.NEURON.2013.06.003 )
  • 4LZ5: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
  • 4LZ7: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
  • 4LZ8: crystal structures of glur2 ligand-binding-domain in complex with glutamate and positive allosteric modulators (10.1021/JM401274B )
  • 4N07: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam-344 at 1.87 a resolution (10.1021/JM4012092 )
  • 4O3A: crystal structure of the glua2 ligand-binding domain in complex with l-aspartate at 1.80 a resolution 14-dec-16 4o3a 1 title (10.1111/FEBS.12795 )
  • 4O3B: crystal structure of an open/closed glua2 ligand-binding domain dimer at 1.91 a resolution (10.1111/FEBS.12795 )
  • 4O3C: crystal structure of the glua2 ligand-binding domain in complex with l-aspartate at 1.50 a resolution 14-dec-16 4o3c 1 title (10.1111/FEBS.12795 )
  • 4U4S: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam25 at 1.90 a resolution. (10.1021/JM501268R )
  • 4U4X: crystal structure of the glua2 ligand-binding domain (s1s2j-l483y- n754s) in complex with glutamate and bpam37 at 1.56 a resolution. (10.1021/JM501268R )
  • 4X48: crystal structure of glur2 ligand-binding core (10.1021/ACS.JMEDCHEM.5B00300 )
  • 4YMA: structure of the ligand-binding domain of glua2 in complex with the antagonist cng10109 (10.1021/ACS.JMEDCHEM.5B00750 )
  • 4YU0: crystal structure of a tetramer of glua2 tr mutant ligand binding domains bound with glutamate at 1.26 angstrom resolution
  • 4Z0I: crystal structure of a tetramer of glua2 ligand binding domains bound with glutamate at 1.45 angstrom resolution
  • 5BUU: crystal structure of the glua2 ligand-binding domain (l483y-n754s) in complex with glutamate and bpam-321 at 2.07 a resolution (10.1021/ACSCHEMNEURO.5B00318 )
  • 5CBR: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (s)-2-amino-3-(3,4-dichloro-5-(5- hydroxypyridin-3-yl)phenyl)propanoic acid at 2.0a resolution (10.1021/ACS.JMEDCHEM.5B01666 )
  • 5CBS: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the antagonist (r)-2-amino-3-(3'-hydroxybiphenyl-3-yl) propanoic acid at 1.8a resolution (10.1021/ACS.JMEDCHEM.5B01666 )
  • 5ELV: crystal structure of the glua2 ligand-binding domain (s1s2j-l504-n775) in complex with glutamate and bpam-521 at 1.92 a resolution (10.1016/J.BPJ.2016.04.032 )
  • 5FHM: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-(aminomethyl)benzyl)-2h-tetrazol- 5-yl)-3-hydroxyisoxazol-4-yl)propanoic acid at resolution 1.55 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
  • 5FHN: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-methylbenzyl)-2h-tetrazol-5-yl)- 3-hydroxyisoxazol-4-yl)propanoic acid at 1.6 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
  • 5FHO: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with (s)-2-amino-3-(5-(2-(3-chlorobenzyl)-2h-tetrazol-5-yl)- 3-hydroxyisoxazol-4-yl)propanoic acid at 2.3 a resolution (10.1021/ACS.JMEDCHEM.5B01982 )
  • 5FWY: crystal structure of the ampa receptor glua2/a3 n-terminal domain heterodimer (10.1126/SCIENCE.AAD3873 )
  • 5H8S: structure of the human glua2 lbd in complex with gne3419 (10.1016/J.NEURON.2016.01.016 )
  • 5IDE: cryo-em structure of glua2/3 ampa receptor heterotetramer (model i) (10.1126/SCIENCE.AAD3873 )
  • 5IDF: cryo-em structure of glua2/3 ampa receptor heterotetramer (model ii) (10.1126/SCIENCE.AAD3873 )
  • 5JEI: crystal structure of the glua2 lbd in complex with fw (10.1038/NCOMMS14327 )
  • 5NG9: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with agonist cip-as at 1.15 a resolution. (10.1021/ACSCHEMNEURO.7B00201 )
  • 5NIH: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with agonist lm-12b at 1.3 a resolution. (10.1021/ACSCHEMNEURO.7B00201 )
  • 5NS9: crystal structure of the glua2 lbd (l483y-n754s-l758v) in complex with glutamate (10.1016/J.BPJ.2017.07.030 )
  • 5O9A: crystal structure of the glua2 ligand-binding domain (s1s2j-l504y- n775s) in complex with glutamate and bpam121 at 1.78 a resolution (10.1021/ACS.JMEDCHEM.7B01323 )
  • 5OEW: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with glutamate and positive allosteric modulator bpam538 (10.1021/ACS.JMEDCHEM.7B01323 )
  • 6FAZ: crystal structure of the glua2 ligand-binding domain (s1s2j) in complex with the positive allosteric modulator tdpam01 at 1.4 a resolution. (10.1021/ACS.JMEDCHEM.8B00250 )
  • 6FLR: super-open structure of the ampar glua3 n-terminal domain (10.1016/J.STR.2018.10.017 )
  • 6FPJ: structure of the ampar glua3 n-terminal domain bound to phosphate (10.1016/J.STR.2018.10.017 )
  • 6FQG: glua2(flop) g724c ligand binding core dimer bound to l-glutamate (form a) at 2.34 angstrom resolution
  • 6FQH: glua2(flop) s729c ligand binding core dimer bound to nbqx at 1.76 angstrom resolution (10.1038/S41467-019-12280-9 )
  • 6FQI: glua2(flop) g724c ligand binding core dimer bound to l-glutamate (form b) at 2.91 angstrom resolution (10.1038/S41467-019-12280-9 )
  • 6FQJ: glua2(flop) g724c ligand binding core dimer bound to zk200775 at 2.50 angstrom resolution (10.1038/S41467-019-12280-9 )
  • 6FQK: glua2(flop) s729c ligand binding core dimer bound to zk200775 at 1.98 angstrom resolution (10.1038/S41467-019-12280-9 )
  • 6GIV: structure of glua2-n775s ligand-binding domain (s1s2j) in complex with glutamate and rubidium bromide at 1.75 a resolution (10.1016/J.NEURON.2019.03.046 )
  • 6GL4: structure of glua2o ligand-binding domain (s1s2j) in complex with glutamate and sodium bromide at 1.95 a resolution (10.1016/J.NEURON.2019.03.046 )
  • 6HC9: structure of glua2 ligand-binding domain (s1s2j-l504y-n775s) in complex with glutamate and tdpam02 at 2.4 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
  • 6HCA: structure of glua2 ligand-binding domain (s1s1j) in complex with positive allosteric modulator tdpam02 at 1.8 a resolution (10.1021/ACSMEDCHEMLETT.8B00369 )
  • 6HCB: structure of glua2 ligand-binding domain (s1s2j-n775s) in complex with glutamate and tdpam01 at 1.9 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
  • 6HCC: structure of glua2 ligand-binding domain (s1s2j-n775s) in complex with glutamate and tdpam02 at 1.6 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
  • 6HCH: structure of glua2 ligand-binding domain (s1s2j-l504y-n775s) in complex with glutamate and tdpam01 at 1.6 a resolution. (10.1021/ACSMEDCHEMLETT.8B00369 )
  • 6NJM: structure of a complex (10.1126/SCIENCE.AAW8250 )
  • 6NJN: structure of a complex (10.1126/SCIENCE.AAW8250 )
  • 6Q54: structure of glua2 ligand-binding domain (s1s2j) in complex with the agonist (s)-2-amino-3-(1-ethyl-4-hydroxy-1h-1,2,3-triazol-5-yl) propanoic acid at 1.4 a resolution (10.1021/ACS.JMEDCHEM.8B01986 )
  • 6Q60: structure of glua2 ligand-binding domain (s1s2j) in complex with the agonist (s)-2-amino-3-(2-methyl-5-hydroxy-2h-1,2,3-triazol-4-yl) propanoic acid at 1.55 a resolution (10.1021/ACS.JMEDCHEM.8B01986 )
  • 6YK2: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-[2'-amino-2'-carboxyethyl]-5,7- dihydrothieno[3,4-d]pyrimidin- 2,4(1h,3h)-dione at resolution 1.60a (10.1021/ACSCHEMNEURO.0C00195 )
  • 6YK3: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound ( s) - 1- [2'-amino-2'-carboxyethyl]-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1h,3h)-dione at resolution 1.20a (10.1021/ACSCHEMNEURO.0C00195 )
  • 6YK4: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound ( s) - 1- [2'-amino-2'-carboxyethyl]-6- methyl-5 ,7- dihydropyrrolo[3,4-d]pyrimidin-2,4(1h,3h)-dione at resolution 1.00a (10.1021/ACSCHEMNEURO.0C00195 )
  • 6YK5: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-(2'-amino-2'-carboxyethyl)-5,7- dihydrofuro[3,4-d]- pyrimidine-2,4(1h,3h)-dione at resolution 1.15a (10.1021/ACSCHEMNEURO.0C00195 )
  • 6YK6: structure of the ampa receptor glua2o ligand-binding domain (s1s2j) in complex with the compound (s)-1-(2'-amino-2'-carboxyethyl)furo[3,4- d]pyrimidin-2,4-dione at resolution 1.47a (10.1021/ACSCHEMNEURO.0C00195 )
  • 7LEP: the composite lbd-tmd structure combined from all hippocampal ampar subtypes at 3.25 angstrom resolution (10.1038/S41586-021-03540-0 )